Company: ARWR
Filing Date: 2025-09-12
Form Type: 8-K
Source: 0000879407-25-000010
Chunk: 1

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-09-12
Form: 8-K
Item: Item 8.01
Chunk 1
---
────────────────────────────────────────
         99.1      Complaint                                                                                             
          104      Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: September 12, 2025

  ARROWHEAD PHARMACEUTICALS, INC.                               
  By:                                  /s/ Daniel Apel          
                                       Daniel Apel              
                                       Chief Financial Officer